BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18253929)

  • 1. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.
    Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
    Ilyinskii PO; Wang R; Balk SP; Exley MA
    J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bovine CD1 family contains group 1 CD1 proteins, but no functional CD1d.
    Van Rhijn I; Koets AP; Im JS; Piebes D; Reddington F; Besra GS; Porcelli SA; van Eden W; Rutten VP
    J Immunol; 2006 Apr; 176(8):4888-93. PubMed ID: 16585584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.
    Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK
    Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.
    Chen Q; Ross AC
    Exp Biol Med (Maywood); 2007 Apr; 232(4):488-94. PubMed ID: 17392484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
    van der Vliet HJ; Molling JW; von Blomberg BM; Kölgen W; Stam AG; de Gruijl TD; Mulder CJ; Janssen HL; Nishi N; van den Eertwegh AJ; Scheper RJ; van Nieuwkerk CJ
    Clin Immunol; 2005 Feb; 114(2):183-9. PubMed ID: 15639652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
    Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
    Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.
    Pereira CS; Pérez-Cabezas B; Ribeiro H; Maia ML; Cardoso MT; Dias AF; Azevedo O; Ferreira MF; Garcia P; Rodrigues E; Castro-Chaves P; Martins E; Aguiar P; Pineda M; Amraoui Y; Fecarotta S; Leão-Teles E; Deng S; Savage PB; Macedo MF
    Front Immunol; 2019; 10():1264. PubMed ID: 31214199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.
    Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG
    J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.